ArabicChineseEnglishFrenchRussianSpanish
WHO home
All WHO This site only
 

Epidemic and Pandemic Alert and Response (EPR)

  Country activities | Outbreak news | Resources | Media centre
  WHO > Programmes and projects > Epidemic and Pandemic Alert and Response (EPR) > Diseases covered by EPR > Avian influenza
printable version

Avian influenza: guidelines. recommendations, descriptions: Previous page | 1,2,3,4,5,6

Vaccines and antivirals

  Table of contents
:: Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as human vaccines
September 2008

:: Availability of new recombinant H5N1 vaccine virus
10 September 2008

:: Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile
May 2008

:: Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003–2006 influenza seasons
27 April 2007, vol. 82, 17 (pp 141–152)

:: Early release of influenza viruses for pandemic influenza vaccine development
01 February 2007

:: Availability of new recombinant H5N1 vaccine virus
21 December 2006

:: Global pandemic influenza action plan to increase vaccine supply
23October 2006

:: WHO procedures for obtaining release of H5N1 sequences to the public domain
23 August 2006

:: Availability of new H5N1 prototype strain for influenza pandemic vaccine development
June 2006

:: Availability of new H5N1 prototype strain for influenza pandemic vaccine development
May 2006

:: WHO Rapid Advice Guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus
May 2006

:: Availability of new H5N1 prototype strain for influenza pandemic vaccine development
March 2006

:: WHO recommended H5N1 prototype strains for influenza pandemic vaccine development remain the same
28 October 2005

:: H5N1 avian influenza – first steps towards development of a human vaccine
12 August 2005

:: Available evidence suggests no need to change the WHO recommended influenza A/H5N1 vaccine prototype strains
20 July 2005

:: Access to influenza A(H5N1) viruses
April 2005

:: Availability of H5N1 prototype strains for influenza pandemic vaccine development
February 2005

:: Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses. Interim biosafety risk assessment.
November 2003

Avian influenza: guidelines. recommendations, descriptions: 1,2,3,4,5,6